Overview:
Rrecombinant rhesus monomeric IgA, designed as a reference standard for quantifying anti-IgA responses in nonhuman primate studies. This reagent features the PGT121-derived antigen-binding domain, ensuring HIV-specific recognition. It replaces the former reference reagent based on the b12 clone, providing an updated and more relevant standard for IgA immune response assessments.
Key Features:
• Monomeric rhesus IgA [MRA] Format: Recombinantly expressed as a fully assembled rhesus IgA monomer, structurally representative of circulating IgA.
• HIV-Specific Targeting: Incorporates the PGT121-derived antigen-binding domain, maintaining HIV-binding specificity.
• Optimized for Immune Response Quantitation: Developed for use in assays measuring anti-IgA responses, particularly in vaccine and therapeutic antibody studies.
• Closest Identity to Rhesus IGHA*04 Allele: Engineered matching the rhesus IGHA*04 allele (AY039248 / Strain RWy2.1).
• Updated Reference Standard: Replaces the former b12-based IgA reagent, ensuring a more relevant tool for evaluating IgA-targeted immunity in rhesus macaques.
Also Available in a Dimeric Form: For studies requiring a dimeric IgA format, see CAT-00429: Rhesus Dimeric IgA aHIV [PGT121DRA].
|